TSXV - Free Realtime Quote CAD

NervGen Pharma Corp. (NGEN.V)

3.5300
-0.0600
(-1.67%)
As of 1:41:49 PM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
24,931.9950
24,931.9950
17,776.7100
23,025.0330
12,811.2240
Operating Income
-24,931.9950
-24,931.9950
-17,776.7100
-23,025.0330
-12,811.2240
Net Non Operating Interest Income Expense
812.6170
812.6170
550.0740
-313.2030
29.4170
Other Income Expense
113.4830
113.4830
-5,155.4840
2,615.9530
55.2290
Pretax Income
-24,005.8950
-24,005.8950
-22,382.1200
-20,722.2830
-12,726.5780
Net Income Common Stockholders
-24,005.8950
-24,005.8950
-22,382.1200
-20,722.2830
-12,726.5780
Diluted NI Available to Com Stockholders
-24,005.8950
-24,005.8950
-22,382.1200
-20,722.2830
-12,726.5780
Basic EPS
-0.36
-0.36
-0.38
-0.39
-0.32
Diluted EPS
-0.36
-0.36
-0.38
-0.39
-0.32
Basic Average Shares
67,321.6980
67,321.6980
59,290.0470
52,649.0350
39,289.2240
Diluted Average Shares
67,321.6980
67,321.6980
59,290.0470
52,649.0350
39,289.2240
Total Expenses
24,931.9950
24,931.9950
17,776.7100
23,025.0330
12,811.2240
Net Income from Continuing & Discontinued Operation
-24,005.8950
-24,005.8950
-22,382.1200
-20,722.2830
-12,726.5780
Normalized Income
-24,119.3780
-24,119.3780
-17,226.6360
-23,338.2360
-12,781.8070
Interest Income
812.6170
812.6170
550.0740
201.3960
29.4170
Interest Expense
--
--
0
514.5990
0
Net Interest Income
812.6170
812.6170
550.0740
-313.2030
29.4170
EBIT
-24,931.9950
-24,931.9950
-17,776.7100
-20,207.6840
-12,726.5780
EBITDA
-24,848.1970
-24,848.1970
-17,631.7080
-20,092.5700
-12,683.9520
Reconciled Depreciation
83.7980
83.7980
145.0020
115.1140
42.6260
Net Income from Continuing Operation Net Minority Interest
-24,005.8950
-24,005.8950
-22,382.1200
-20,722.2830
-12,726.5780
Total Unusual Items Excluding Goodwill
113.4830
113.4830
-5,155.4840
2,615.9530
55.2290
Total Unusual Items
113.4830
113.4830
-5,155.4840
2,615.9530
55.2290
Normalized EBITDA
-24,961.6800
-24,961.6800
-12,476.2240
-22,708.5230
-12,739.1810
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/15/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MSCL.TO Satellos Bioscience Inc.
0.6400
-1.54%
 
RZLT Rezolute, Inc.
3.6650
-1.48%
 
APS.TO Aptose Biosciences Inc.
2.1900
-1.35%
 
KNE.V Kane Biotech Inc.
0.0750
-6.25%
 
ALDX Aldeyra Therapeutics, Inc.
2.2000
+1.85%
 
PMN ProMIS Neurosciences, Inc.
0.4876
-2.48%
 
MDNAF Medicenna Therapeutics Corp.
0.7600
+8.57%
 
PYPD PolyPid Ltd.
2.8000
+0.36%
 
EPRX Eupraxia Pharmaceuticals Inc.
3.8000
0.00%
 
MDNA.TO Medicenna Therapeutics Corp.
1.0700
+7.00%